These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11775088)

  • 1. Clinician perspective on achieving and maintaining remission in depression.
    Kelsey JE
    J Clin Psychiatry; 2001; 62 Suppl 26():16-21. PubMed ID: 11775088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical, psychosocial, and pharmacoeconomic ramifications of remission.
    Thase ME
    Am J Manag Care; 2001 Sep; 7(11 Suppl):S377-85. PubMed ID: 11570028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving remission and managing relapse in depression.
    Thase ME
    J Clin Psychiatry; 2003; 64 Suppl 18():3-7. PubMed ID: 14700448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human cost of not achieving full remission in depression.
    McIntyre RS; O'Donovan C
    Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):10S-16S. PubMed ID: 15147032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving remission in major depressive disorder: the first step to long-term recovery.
    Kelsey JE
    J Am Osteopath Assoc; 2004 Mar; 104(3 Suppl 3):S6-10. PubMed ID: 15083991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the ideal antidepressant therapy to achieve remission.
    Ferrier IN
    J Clin Psychiatry; 2001; 62 Suppl 26():10-5. PubMed ID: 11775087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.
    Schramm E; Schneider D; Zobel I; van Calker D; Dykierek P; Kech S; Härter M; Berger M
    J Affect Disord; 2008 Jul; 109(1-2):65-73. PubMed ID: 18067973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special issues in the management of depression in older patients.
    Rabheru K
    Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):41S-50S. PubMed ID: 15147035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for generalized anxiety disorder.
    Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
    Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in antidepressant therapy in special populations.
    Hayes D
    Am J Manag Care; 2004 Jul; 10(6 Suppl):S179-85. PubMed ID: 15354675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the efficacy of antidepressants with psychotherapy.
    Petersen TJ
    J Psychopharmacol; 2006 May; 20(3 Suppl):19-28. PubMed ID: 16644768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
    Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
    Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving remission in major depressive disorder: the first step to long-term recovery.
    Kelsey JE
    J Am Osteopath Assoc; 2004 Mar; 104(3 Suppl 1):S6-10. PubMed ID: 16493144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
    Van HL; Dekker J; Peen J; van Aalst G; Schoevers RA
    Psychother Psychosom; 2008; 77(6):358-64. PubMed ID: 18701832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for refractory depression.
    Shelton RC
    J Clin Psychiatry; 1999; 60 Suppl 4():57-61; discussion 62-3. PubMed ID: 10086483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.